vs
AMERICAN REALTY INVESTORS INC（ARL）与太平洋生物科学（ASMB）财务数据对比。点击上方公司名可切换其他公司
AMERICAN REALTY INVESTORS INC的季度营收约是太平洋生物科学的1.2倍（$13.0M vs $10.8M），AMERICAN REALTY INVESTORS INC净利率更高（75.2% vs -85.2%，领先160.4%），太平洋生物科学同比增速更快（57.6% vs 8.1%）
原温加顿地产投资者是一家房地产投资信托公司，主要投资于美国南部的购物中心，且项目大多以杂货店作为主力店。该公司在2021年8月被金考地产收购。
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
ARL vs ASMB — 直观对比
营收规模更大
ARL
是对方的1.2倍
$10.8M
营收增速更快
ASMB
高出49.5%
8.1%
净利率更高
ARL
高出160.4%
-85.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.0M | $10.8M |
| 净利润 | $9.8M | $-9.2M |
| 毛利率 | — | — |
| 营业利润率 | -23.3% | -100.9% |
| 净利率 | 75.2% | -85.2% |
| 营收同比 | 8.1% | 57.6% |
| 净利润同比 | 6175.8% | 4.3% |
| 每股收益（稀释后） | $0.60 | $-0.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARLASMB
| Q4 25 | $13.0M | — | ||
| Q3 25 | $12.8M | $10.8M | ||
| Q2 25 | $12.2M | $9.6M | ||
| Q1 25 | $12.0M | $9.4M | ||
| Q4 24 | $12.0M | $7.4M | ||
| Q3 24 | $11.6M | $6.8M | ||
| Q2 24 | $11.8M | $8.5M | ||
| Q1 24 | $11.9M | $5.8M |
净利润ARLASMB
| Q4 25 | $9.8M | — | ||
| Q3 25 | $129.0K | $-9.2M | ||
| Q2 25 | $2.8M | $-10.2M | ||
| Q1 25 | $3.0M | $-8.8M | ||
| Q4 24 | $-161.0K | — | ||
| Q3 24 | $-17.5M | $-9.6M | ||
| Q2 24 | $1.2M | $-11.2M | ||
| Q1 24 | $1.8M | $-9.1M |
营业利润率ARLASMB
| Q4 25 | -23.3% | — | ||
| Q3 25 | -12.3% | -100.9% | ||
| Q2 25 | -8.3% | -115.2% | ||
| Q1 25 | -6.8% | -105.5% | ||
| Q4 24 | -14.8% | — | ||
| Q3 24 | -17.8% | -160.1% | ||
| Q2 24 | -10.8% | -143.0% | ||
| Q1 24 | -12.7% | -185.5% |
净利率ARLASMB
| Q4 25 | 75.2% | — | ||
| Q3 25 | 1.0% | -85.2% | ||
| Q2 25 | 23.2% | -105.9% | ||
| Q1 25 | 24.7% | -93.6% | ||
| Q4 24 | -1.3% | — | ||
| Q3 24 | -150.4% | -140.4% | ||
| Q2 24 | 9.9% | -130.7% | ||
| Q1 24 | 14.7% | -156.9% |
每股收益（稀释后）ARLASMB
| Q4 25 | $0.60 | — | ||
| Q3 25 | $0.01 | $-0.72 | ||
| Q2 25 | $0.18 | $-1.33 | ||
| Q1 25 | $0.18 | $-1.17 | ||
| Q4 24 | $-0.01 | — | ||
| Q3 24 | $-1.08 | $-1.51 | ||
| Q2 24 | $0.07 | $-1.98 | ||
| Q1 24 | $0.11 | $-1.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.1M | $22.5M |
| 总债务越低越好 | $214.4M | — |
| 股东权益账面价值 | $617.4M | $182.7M |
| 总资产 | $1.1B | $240.0M |
| 负债/权益比越低杠杆越低 | 0.35× | — |
8季度趋势，按日历期对齐
现金及短期投资ARLASMB
| Q4 25 | $89.1M | — | ||
| Q3 25 | $82.8M | $22.5M | ||
| Q2 25 | $73.5M | $24.0M | ||
| Q1 25 | $88.7M | $23.4M | ||
| Q4 24 | $99.7M | $38.3M | ||
| Q3 24 | $131.6M | $28.5M | ||
| Q2 24 | $127.5M | $19.2M | ||
| Q1 24 | $130.9M | $18.7M |
总债务ARLASMB
| Q4 25 | $214.4M | — | ||
| Q3 25 | $227.0M | — | ||
| Q2 25 | $216.0M | — | ||
| Q1 25 | $201.7M | — | ||
| Q4 24 | $185.4M | — | ||
| Q3 24 | $183.8M | — | ||
| Q2 24 | $181.0M | — | ||
| Q1 24 | $181.8M | — |
股东权益ARLASMB
| Q4 25 | $617.4M | — | ||
| Q3 25 | $607.8M | $182.7M | ||
| Q2 25 | $607.8M | $18.1M | ||
| Q1 25 | $604.9M | $27.1M | ||
| Q4 24 | $601.8M | $33.4M | ||
| Q3 24 | $602.2M | $26.0M | ||
| Q2 24 | $619.9M | $34.7M | ||
| Q1 24 | $618.8M | $32.6M |
总资产ARLASMB
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $240.0M | ||
| Q2 25 | $1.1B | $80.8M | ||
| Q1 25 | $1.0B | $99.0M | ||
| Q4 24 | $1.0B | $119.2M | ||
| Q3 24 | $1.0B | $100.3M | ||
| Q2 24 | $1.0B | $115.3M | ||
| Q1 24 | $1.0B | $119.9M |
负债/权益比ARLASMB
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.37× | — | ||
| Q2 25 | 0.36× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.6M | $-15.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-15.2M |
| 自由现金流率自由现金流/营收 | — | -140.7% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | -0.57× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ARLASMB
| Q4 25 | $-5.6M | — | ||
| Q3 25 | $8.0M | $-15.1M | ||
| Q2 25 | $-2.9M | $-16.8M | ||
| Q1 25 | $-7.4M | $-23.4M | ||
| Q4 24 | $1.1M | $-51.1M | ||
| Q3 24 | $13.5M | $-15.2M | ||
| Q2 24 | $-503.0K | $-17.1M | ||
| Q1 24 | $3.9M | $-18.4M |
自由现金流ARLASMB
| Q4 25 | — | — | ||
| Q3 25 | — | $-15.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-17.1M | ||
| Q1 24 | — | $-18.4M |
自由现金流率ARLASMB
| Q4 25 | — | — | ||
| Q3 25 | — | -140.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -695.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -200.6% | ||
| Q1 24 | — | -317.7% |
资本支出强度ARLASMB
| Q4 25 | — | — | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.2% |
现金转化率ARLASMB
| Q4 25 | -0.57× | — | ||
| Q3 25 | 61.81× | — | ||
| Q2 25 | -1.03× | — | ||
| Q1 25 | -2.50× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.43× | — | ||
| Q1 24 | 2.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
